EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Integrative bulk and single-cell transcriptomics identifies a HERC5-linked immune-attenuated risk program for pulmonary metastasis/relapse in osteosarcoma

Zhangfu Li, Baicheng Yang, Shiqing Liu, Shengji Yu

Translational Oncology · 2026-12 · 74 · 103070

DOI: 10.1016/j.tranon.2026.103070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Oncology, 2026-12. Verfasst von Zhangfu Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences a…. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pulmonary metastasis/relapse (PM/R) is a major cause of osteosarcoma treatment failure. We aimed to develop a compact transcriptomic PM/R risk score and characterize associated immune and single-cell programs. METHODS: TARGET-OS bulk RNA-seq was used for discovery and GSE21257 for external validation. Differential expression, multi-algorithm feature selection and LASSO regression were used to construct the score. Clinical associations were assessed by PM/R classification, survival and calibration analyses. Immune signature scoring, weighted gene co-expression network analysis (WGCNA), single-cell projection, in silico virtual HERC5 knockout, PROGENy/DoRothEA, CellChat and exploratory drug-reversal analyses were used for biological interpretation. RESULTS: A 9-gene score comprising HERC5, GPR141, SLC45A4, LCN15, MXI1, UCK2, KRTAP13-2, KCNK6 and TRABD2A showed high apparent discrimination in TARGET-OS (AUC = 0.922). A reduced seven-gene GSE21257 implementation achieved an AUC of 0.728. High-risk tumors were enriched for PM/R and had poorer event-free survival (HR = 3.14, 95% CI, 1.60-6.16) and overall survival (HR = 3.75, 95% CI, 1.60-8.79). High-risk disease showed reduced antigen-presentation, IFN-gamma, T-cell, CD8 T-cell, NK-cell and cytotoxicity signatures. WGCNA identified a protective immune module, while single-cell and in silico virtual-knockout analyses prioritized HERC5 as a candidate immune-associated node linked to antigen-presentation genes. Regulatory and communication analyses suggested reduced JAK-STAT/IRF activity and SPP1/MIF-centered microenvironmental signaling. CONCLUSIONS: This study defines a PM/R-focused transcriptomic risk score and links high-risk osteosarcoma to immune attenuation and a HERC5-associated antigen-presentation program, providing a framework for future validation.

Schlagwörter

Stichwörter der Autor:innen

Antigen presentationHERC5OsteosarcomaPulmonary metastasis/relapseSingle-cell RNA sequencing

Autor:innen und Institutionen

  • Department of Orthopedics, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Department of Orthopedics, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, Z., Yang, B., Liu, S., & Yu, S. (2026). Integrative bulk and single-cell transcriptomics identifies a HERC5-linked immune-attenuated risk program for pulmonary metastasis/relapse in osteosarcoma. Translational Oncology, 74, 103070. https://doi.org/10.1016/j.tranon.2026.103070

Vancouver

Li Z, Yang B, Liu S, Yu S. Integrative bulk and single-cell transcriptomics identifies a HERC5-linked immune-attenuated risk program for pulmonary metastasis/relapse in osteosarcoma. Translational Oncology. 2026;74:103070. doi:10.1016/j.tranon.2026.103070

BibTeX
@article{Li2026,
  author = {Li, Zhangfu and Yang, Baicheng and Liu, Shiqing and Yu, Shengji},
  title = {Integrative bulk and single-cell transcriptomics identifies a HERC5-linked immune-attenuated risk program for pulmonary metastasis/relapse in osteosarcoma},
  journal = {Translational Oncology},
  year = {2026},
  volume = {74},
  pages = {103070},
  doi = {10.1016/j.tranon.2026.103070}
}
Kostenlos starten →